异动解读｜Elevance Health盘中上涨3.04%，高管增持与Q2业绩超预期支撑股价

行情直击

Aug 19

8月18日，Elevance Health盘中上涨3.04%，报402.115美元/股，成交额2.08亿美元。

消息面上，公司CEO Gail Boudreaux与董事长Ramiro Peru于7月17日分别增持约100万美元及36.6万美元股份，买入价约367.79美元，被Smart Insider列为本周精选标的。这是Boudreaux就任CEO以来第三次增持，买入价较去年287美元高出约28%，机构认为这一信号具有积极意义。

基本面方面，公司Q2调整后每股收益7.45美元，大幅超出市场预期的6.21美元，营收498.3亿美元同比增长0.8%。公司上调全年调整后每股收益指引至不低于27美元。多家机构上调目标价，Guggenheim升至455美元，Wells Fargo升至492美元，当前分析师平均目标价约445美元，市场情绪偏积极。

Elevance Health是美国领先的健康保险公司，以Blue Cross和Blue Shield授权商身份运营，服务约4520万名医疗成员，业务涵盖Health Benefits、CarelonRx、Carelon Services等分部。

（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1156006255"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156006255\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156006255?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-08-19 03:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156006255","market":"us","top_or_hot":-1,"title":"异动解读｜Elevance Health盘中上涨3.04%，高管增持与Q2业绩超预期支撑股价","media":"行情直击","content":"<p><p>8月18日，Elevance Health盘中上涨3.04%，报402.115美元/股，成交额2.08亿美元。</p><p>消息面上，公司CEO Gail Boudreaux与董事长Ramiro Peru于7月17日分别增持约100万美元及36.6万美元股份，买入价约367.79美元，被Smart Insider列为本周精选标的。这是Boudreaux就任CEO以来第三次增持，买入价较去年287美元高出约28%，机构认为这一信号具有积极意义。</p><p>基本面方面，公司Q2调整后每股收益7.45美元，大幅超出市场预期的6.21美元，营收498.3亿美元同比增长0.8%。公司上调全年调整后每股收益指引至不低于27美元。多家机构上调目标价，Guggenheim升至455美元，Wells Fargo升至492美元，当前分析师平均目标价约445美元，市场情绪偏积极。</p><p>Elevance Health是美国领先的健康保险公司，以Blue Cross和Blue Shield授权商身份运营，服务约4520万名医疗成员，业务涵盖Health Benefits、CarelonRx、Carelon Services等分部。</p><p>（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读｜Elevance Health盘中上涨3.04%，高管增持与Q2业绩超预期支撑股价</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读｜Elevance Health盘中上涨3.04%，高管增持与Q2业绩超预期支撑股价\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1059448697\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">行情直击 </p>\n<p class=\"h-time\">2026-08-19 03:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>8月18日，Elevance Health盘中上涨3.04%，报402.115美元/股，成交额2.08亿美元。</p><p>消息面上，公司CEO Gail Boudreaux与董事长Ramiro Peru于7月17日分别增持约100万美元及36.6万美元股份，买入价约367.79美元，被Smart Insider列为本周精选标的。这是Boudreaux就任CEO以来第三次增持，买入价较去年287美元高出约28%，机构认为这一信号具有积极意义。</p><p>基本面方面，公司Q2调整后每股收益7.45美元，大幅超出市场预期的6.21美元，营收498.3亿美元同比增长0.8%。公司上调全年调整后每股收益指引至不低于27美元。多家机构上调目标价，Guggenheim升至455美元，Wells Fargo升至492美元，当前分析师平均目标价约445美元，市场情绪偏积极。</p><p>Elevance Health是美国领先的健康保险公司，以Blue Cross和Blue Shield授权商身份运营，服务约4520万名医疗成员，业务涵盖Health Benefits、CarelonRx、Carelon Services等分部。</p><p>（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ELV","symbol_name":"Elevance Health","start_time":0,"source_url":"","article_id":"1156006255","we_media_id":"1059448697","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156006255","pubTimestamp":1787080535,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"行情直击","introduction":"个股异动一手消息解读","home_visible":1,"id":"1059448697","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"8月18日，Elevance Health盘中上涨3.04%，报402.115美元/股，成交额2.08亿美元。消息面上，公司CEO Gail Boudreaux与董事长Ramiro Peru于7月17日分别增持约100万美元及36.6万美元股份，买入价约367.79美元，被Smart Insider列为本周精选标的。公司上调全年调整后每股收益指引至不低于27美元。Elevance Health是美国领先的健康保险公司，以Blue Cross和Blue Shield授权商身份运营，服务约4520万名医疗成员，业务涵盖Health Benefits、CarelonRx、Carelon Services等分部。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ELV":"Elevance Health"},"translate_title":"Movement Interpretation | Elevance Health rose 3.04% intraday, with executive overweight and Q2 results beating expectations supporting the stock price","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELV":1},"content_text":"8月18日，Elevance Health盘中上涨3.04%，报402.115美元/股，成交额2.08亿美元。消息面上，公司CEO Gail Boudreaux与董事长Ramiro Peru于7月17日分别增持约100万美元及36.6万美元股份，买入价约367.79美元，被Smart Insider列为本周精选标的。这是Boudreaux就任CEO以来第三次增持，买入价较去年287美元高出约28%，机构认为这一信号具有积极意义。基本面方面，公司Q2调整后每股收益7.45美元，大幅超出市场预期的6.21美元，营收498.3亿美元同比增长0.8%。公司上调全年调整后每股收益指引至不低于27美元。多家机构上调目标价，Guggenheim升至455美元，Wells Fargo升至492美元，当前分析师平均目标价约445美元，市场情绪偏积极。Elevance Health是美国领先的健康保险公司，以Blue Cross和Blue Shield授权商身份运营，服务约4520万名医疗成员，业务涵盖Health Benefits、CarelonRx、Carelon Services等分部。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}